Return to Statistics Toolbox

Pathway mapping for Study ST002225

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Cell line:786-M1A | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:10 mins (6)
Cell line:786-M1A | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:1 hour (6)
Cell line:786-M1A | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:3 hours (6)
Cell line:786-O | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:10 mins (6)
Cell line:786-O | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:1 hour (6)
Cell line:786-O | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:3 hours (6)
Cell line:HK2 | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:10 mins (6)
Cell line:HK2 | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:1 hour (6)
Cell line:HK2 | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:3 hours (6)
Cell line:OSLM1B | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:10 mins (6)
Cell line:OSLM1B | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:1 hour (6)
Cell line:OSLM1B | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:3 hours (6)
Cell line:OSRC2 | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:10 mins (6)
Cell line:OSRC2 | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:1 hour (6)
Cell line:OSRC2 | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:3 hours (6)
Cell line:RFX631 | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:10 mins (6)
Cell line:RFX631 | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:1 hour (6)
Cell line:RFX631 | Treatment:13C6-leucine+13C6-isoleucine | Treatment duration:3 hours (6)
Limit by pathway class:
Analysis:Combine data for all analyses?:     

  logo